We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$3.16B
1-Year Est. Return
109.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.68%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.12B
AUM Growth
+$203M
(+11%)
Cap. Flow
+$211M
Cap. Flow
% of AUM
9.97%
Top 10 Holdings %
Top 10 Hldgs %
14.86%
Holding
360
New
30
Increased
165
Reduced
80
Closed
40
Top Buys
| 1 |
PENN Entertainment
PENN
|
+$14.7M |
| 2 |
Axos Financial
AX
|
+$14.7M |
| 3 |
BLUE
bluebird bio
BLUE
|
+$12.4M |
| 4 |
Korn Ferry
KFY
|
+$11.9M |
| 5 |
IPXL
Impax Laboratories, Inc.
IPXL
|
+$10.6M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
+$11.7M |
| 2 |
AWAY
HOMEAWAY INC COM
AWAY
|
+$8.46M |
| 3 |
Astronics
ATRO
|
+$8.33M |
| 4 |
FARO
Faro Technologies
FARO
|
+$8.25M |
| 5 |
Ametek
AME
|
+$8.02M |
Sector Composition
| 1 | Technology | 18.78% |
| 2 | Financials | 18.18% |
| 3 | Consumer Discretionary | 14.47% |
| 4 | Healthcare | 14.27% |
| 5 | Industrials | 12.24% |
Similar funds
AWE
FTUS
BFA
BP
CVA
DWP
GKWIM
BI
Emerald Advisers's Q4 2015 Portfolio in Review
As of Q4 2015, Emerald Advisers held 360 positions worth $2.12B, up 11% from $1.91B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Emerald Advisers deployed $211M of net new capital in Q4 2015, opening 30 new positions and adding to 165 existing holdings. Its largest new stake was PENN Entertainment: 875,543 shares worth $14M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Faro Technologies, an estimated $8.25M trimmed.
- Emerald Advisers's largest Q4 2015 buy was PENN Entertainment: 875,543 shares worth $14M.
- Emerald Advisers added most to Axos Financial in Q4 2015, an estimated $14.7M increase.
- Emerald Advisers's biggest Q4 2015 reduction was Faro Technologies, cutting an estimated $8.25M.
- Emerald Advisers fully exited Sarepta Therapeutics in Q4 2015, selling an estimated $11.7M.
- Emerald Advisers's ten largest holdings make up 15% of its $2.12B portfolio in Q4 2015.
- Emerald Advisers opened 30 new positions and closed 40 in Q4 2015.
- Emerald Advisers's portfolio value rose 11% quarter-over-quarter to $2.12B.
Based on Emerald Advisers's 13F filing for Q4 2015, filed 25 Jan 2016.